COVID-19 is a pneumonia-like disease that was first identified in Wuhan, China. The disease is caused by a new coronavirus, named SARS-CoV-2, that is similar to the Severe Acute Respiratory Syndrome (SARS) virus.
Shaping the U.S. Response
Nov. 12: ASM Urges Congress to Complete FY 2021 Appropriations Process
Oct. 23: ASM Advocates for Equitable Access to Future COVID-19 Vaccine
Leading on Diagnostics & Testing
Nov. 18: SARS-CoV-2 Testing: Sensitivity Is Not the Whole Story
Oct. 6: ASM and Partners Call for Transparency Regarding COVID-19 Testing Supplies
Facilitating Research
Nov. 20: MMR Vaccine Could Protect Against COVID-19
Oct. 30: Washing Hands and Halloween Candy can Mitigate COVID-19 Contamination Risks
Providing Trusted Information
Dec 16: COVID-19 Webinar: Revving Up to Warp Speed
Dec. 4: COVID-19 Vaccine FAQs
Oct. 27: COVID-19 and the Flu
Top COVID-19 Questions, Answered
COVID-19 on This Week in Virology (TWiV)
Nov. 19, 2020
mRNA vaccines from Moderna and Pfizer show over 90% efficacy, prothrombotic auto-antibodies in serum of COVID-19 patients and the whereabouts of SARS-CoV-2 in the human body.
Source: Johns Hopkins University Center for Systems Science and Engineering
ASM Leadership Speaks to the Media
Reuters: Childhood vaccine linked to less severe COVID-19, cigarette smoke raises risk
Pittsburgh Post-Gazette: Pitt COVID-19 vaccine effort with partners in France, Austria seeks win for all of us ASM member Dr. Paul Duprex speaks about vaccine development partnership.
Resources for You
COVID-19 Infographics
COVID-19 Pandemic Timeline
Comparison of COVID-19 Molecular and Antibody Tests
Vaccine Candidates Based on SARS-CoV-2
